FDA probe looks into unauthorized herpes vaccine research
The criminal investigation examines research by a Southern Illinois University professor who injected people with his unauthorized herpes vaccine.
HIV research misconduct accusations loom over likely CDC pick
Dr. Robert Redfield, Trump's likely pick to lead the CDC, is facing significant criticism because of a 20-year-old controversy over shoddy HIV research.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Southern Illinois University halts herpes research amidst investigation into clinical trial practices
SIU professor William Halford had injected Americans with his experimental herpes vaccine in St. Kitts and Nevis in 2016 and in Illinois hotel rooms in 2013 without routine safety oversight from the Food and Drug Administration, according to ongoing reporting by KHN.
A ‘rogue’ clinical trial for herpes vaccine highlights the risks of flouting FDA regulations
"This researcher went rogue," said Fernandez Lynch, the lawyer who specializes in medical ethics. "When one of their own goes rogue, a university should launch an aggressive investigation, interview the participants and make sure it never happens again."
St. Kitts and Nevis officials investigate Rational Vaccines over herpes vaccine clinical trial
The government officials contend that researchers did not officially seek permission for the trial, which took place from April to August 2016.
An offshore clinical trial for herpes vaccine tests new regulatory landscape
Neither the Food and Drug Administration nor a safety panel known as an institutional review board, or an “IRB,” monitored the testing of a vaccine its creators say prevents herpes outbreaks.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Price made dozens of health stock trades even as committee was investigated
Craig Holman, government affairs lobbyist with Public Citizen, described Price’s volume of stock trades during the SEC inquiry as “brazen,” given the congressman’s access to nonpublic information affecting the companies’ fortunes.